These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28635304)

  • 1. The Relationship Between the Neutrophil-Lymphocyte Ratio and In-Stent Restenosis in Patients With Femoropopliteal Chronic Total Occlusions.
    Chang Z; Zheng J; Liu Z; Guo Q
    Angiology; 2018 Feb; 69(2):177-182. PubMed ID: 28635304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Preprocedural Laboratory Parameters as Predictors of Drug-Eluting Stent Restenosis in Coronary Chronic Total Occlusion Lesions.
    Li C; Shen Y; Xu R; Dai Y; Chang S; Lu H; Dong Z; Deng J; Qian J; Ge J
    Angiology; 2019 Mar; 70(3):272-278. PubMed ID: 29338303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
    J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Eluting Stent vs Percutaneous Transluminal Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis: Results From a Retrospective 1-Year Multicenter Study.
    Murata N; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Yokoi H; Tosaka A; Tanaka N; Iida O
    J Endovasc Ther; 2016 Aug; 23(4):642-7. PubMed ID: 27099284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Neutrophil-Lymphocyte Ratio and Drug-Coated Balloon Restenosis in Patients With Femoropopliteal Arterial Disease.
    Pan T; Tian SY; Liu Z; Zhang T; Li C; Ji DH; Wang F
    Angiology; 2023 Mar; 74(3):252-258. PubMed ID: 35575010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the neutrophil to lymphocyte ratio for prediction of in-stent restenosis in bifurcation lesions.
    Balli M; Taşolar H; Çetin M; Tekin K; Çağliyan ÇE; Türkmen S; Yilmaz M; Elbasan Z; Şahin DY; Çayli M
    Eur Rev Med Pharmacol Sci; 2015 May; 19(10):1866-73. PubMed ID: 26044233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2016 Apr; 9(8):828-834. PubMed ID: 27101908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification and clinical impact of restenosis after femoropopliteal stenting.
    Tosaka A; Soga Y; Iida O; Ishihara T; Hirano K; Suzuki K; Yokoi H; Nanto S; Nobuyoshi M
    J Am Coll Cardiol; 2012 Jan; 59(1):16-23. PubMed ID: 22192663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
    Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil to Lymphocyte Ratio as a Predictor of Restenosis After Angioplasty and Stenting for Asymptomatic Carotid Stenosis.
    Dai Z; Li R; Zhao N; Han Y; Wang M; Zhang S; Bai Y; Li Z; Liang M; Xiao L; Ma M; Liu X; Xu G
    Angiology; 2019 Feb; 70(2):160-165. PubMed ID: 29940783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation.
    Nakazawa KR; Wengerter SP; Power JR; Lookstein RA; Tadros RO; Ting W; Faries PL; Vouyouka AG
    J Vasc Surg; 2017 Jul; 66(1):151-159. PubMed ID: 28259571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of coronary collateral circulation on angiographic in-stent restenosis in patients with stable coronary artery disease and chronic total occlusion.
    Yang ZK; Shen Y; Hu J; Zhang Q; Ding FH; Zhang RY; Lu L; Shen WF
    Int J Cardiol; 2017 Jan; 227():485-489. PubMed ID: 27836292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravascular ultrasound measurements after drug-eluting stent placement in femoropopliteal lesions: determining predictors of restenosis.
    Mori S; Hirano K; Nakano M; Muramatsu T; Tsukahara R; Ito Y; Ishimori H
    J Endovasc Ther; 2015 Jun; 22(3):341-9. PubMed ID: 25862363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Angioscopic Evaluation for Femoropopliteal In-Stent Restenosis Before and After Excimer Laser Atherectomy.
    Idemoto A; Okamoto N; Tanaka A; Mori N; Nakamura D; Yano M; Makino N; Egami Y; Shutta R; Tanouchi J; Nishino M
    Vasc Endovascular Surg; 2017 Jul; 51(5):335-337. PubMed ID: 28486842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis.
    Turak O; Ozcan F; Isleyen A; Tok D; Sokmen E; Buyukkaya E; Aydogdu S; Akpek M; Kaya MG
    Am J Cardiol; 2012 Nov; 110(10):1405-10. PubMed ID: 22858185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiographic patterns of restenosis after percutaneous intervention of chronic total occlusive lesions with drug-eluting stents.
    Lee SP; Shin DH; Park KW; Kang HJ; Koo BK; Cho YS; Yeon TJ; Chae IH; Choi DJ; Kim HS
    Int J Cardiol; 2012 Apr; 156(2):180-5. PubMed ID: 21109317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
    Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
    EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.